Folio · SPXSet Report · Digest
v0.7.0 STABLE · 2026-11-11 · r4

2026-W46 · Nov 9–Nov 15 · Company · Profile · published

Index >>> Company >>> Profile

International Flavors & Fragrances Inc. (IFF) — XLB Materials · S&P 500 Profile |國際香精香料公司介紹

materialsS&P500xlbxlb-top-25
SPXSet Studio
IN-HOUSE RESEARCH · 站內獨立研究

International Flavors & Fragrances Inc. (IFF) — Business, History & S&P 500 Profile |國際香精香料公司介紹

International Flavors & Fragrances company profile · taste, food ingredients, health & biosciences, scent · history · financial snapshot · S&P 500 rank #376 · 國際香精香料公司業務歷史財務與標普500地位

中文版 ↓

PROFILE
Market data as of Nov 3, 2026 (benchmark snapshot)
Financials: FY2025 (ended Dec 31, 2025)
MARKET CAP
$23.52B
Nov 3, 2026 (StockAnalysis)
S&P 500 WEIGHT
0.03%
Rank #376 · Nov 3, 2026 (Slickcharts)
FY2025 NET SALES
$10.89B
−5% reported YoY
FY2025 ADJ. OPERATING EBITDA
$2.09B
19.2% margin

SNAPSHOT

TickerIFF (NYSE)
CompanyInternational Flavors & Fragrances Inc.
GICS sector / industryMaterials / Specialty Chemicals
S&P 500 rank (by weight)#376 · 0.03% (Nov 3, 2026)
Sector rank (by S&P 500 weight)#14 in Materials (Nov 3, 2026)
HeadquartersNew York City, New York
Founded1889 (Polak & Schwarz; IFF formed 1958)
CEOErik Fyrwald (since February 2024)
Market cap$23.52B (Nov 3, 2026)
SEC filingsEDGAR — CIK 0000051253

WHAT IT DOES

IFF creates the taste, scent and functional ingredients inside other companies’ products: flavours and savoury solutions, food ingredients and protection systems, enzymes, cultures and probiotics, fragrance compounds and cosmetic actives. Customers are food, beverage, household, personal-care and pharmaceutical manufacturers; IFF rarely reaches the consumer under its own name, so its growth is won in customer formulations and new-product wins.

FY2025 net sales were $10,890M, down 5% reported from $11,484M in FY2024, but up 2% on a comparable currency-neutral basis. Gross profit was $3,938M (36.2% margin, computed) and adjusted operating EBITDA was $2,090M, a 19.2% margin. The reported GAAP result was a loss, driven by a $1,153M Food Ingredients goodwill impairment and divestiture-related charges; the GAAP net-loss dollar figure is not stated here because it was not verified from the 10-K text accessed (see the financial note).

The portfolio is being deliberately shrunk toward its strongest franchises: in 2025 IFF split the former Nourish segment into Taste and Food Ingredients, sold Pharma Solutions and its nitrocellulose business, launched a sale process for Food Ingredients, and in May 2026 agreed to sell Food Ingredients to CVC Capital Partners. From the second quarter of 2026 Food Ingredients is reported as discontinued operations.

SEGMENT NET SALES — FY2025

SegmentNet salesShareYoY
Food Ingredients$3,278M30.1%−3%*
Taste$2,481M22.8%+4%*
Scent$2,479M22.8%+3%*
Health & Biosciences$2,283M21.0%+3%*
Pharma Solutions$369M3.4%—
Total net sales$10,890M100%−5%
Source: IFF FY2025 Form 10-K segment disclosure. Shares are computed from segment net sales and sum to 100% subject to rounding. *Segment YoY figures are comparable currency-neutral growth rates reported by the company, not reported-dollar YoY: reported-dollar prior-year segment sales under the 2025 Taste/Food Ingredients split were not verified from the 10-K text accessed, so no reported-dollar segment YoY is stated. Pharma Solutions YoY is shown as — because the business was sold during 2025 and only part-year sales are included. Segment adjusted operating EBITDA FY2025: Taste $478M, Health & Biosciences $594M, Scent $515M; Food Ingredients and Pharma Solutions adjusted operating EBITDA are not stated here because they were not verified from the 10-K text accessed.

HISTORY

YearMilestone
1889Polak & Schwarz founded in Zutphen, Netherlands, by Leopold Schwarz and Joseph Polak, trading in spices, flavours and fragrances
1958Merger of Polak & Schwarz and van Ameringen-Haebler forms International Flavors & Fragrances
2018Acquires Frutarom, expanding natural flavours, savoury and natural ingredients
2021Merger with DuPont Nutrition & Biosciences creates the enlarged IFF ingredients and biosciences platform
2025Former Nourish segment split into Taste and Food Ingredients; Pharma Solutions and nitrocellulose sold; $1,153M Food Ingredients goodwill impairment recognized; formal sale process for Food Ingredients launched

COMPETITIVE POSITION

  • Formulation lock-in — once an IFF flavour, enzyme or fragrance is specified in a customer’s product, reformulation is costly and slow, giving multi-year revenue visibility that commodity chemical suppliers lack.
  • Scale in scent and taste — Scent ($2,479M) and Taste ($2,481M) are near-equal second engines beside Food Ingredients, and Health & Biosciences earns the highest segment adjusted EBITDA margin of the three disclosed segments (26%, per the company summary).
  • Bioscience depth — enzymes, cultures and probiotics from the DuPont N&B merger give IFF a health-and-nutrition growth path beyond flavours and fragrances.
  • Competition — Givaudan, Symrise, DSM-Firmenich, Novonesis, Kerry and ADM contest flavours, fragrances and bioscience ingredients on innovation, natural-ingredient sourcing and price.

FINANCIAL SNAPSHOT — FY2025

Net sales$10,890M (−5% reported YoY; +2% comparable currency-neutral)
Gross profit$3,938M (36.2% margin, computed)
Adjusted operating EBITDA$2,090M (19.2% margin)
Adjusted EPS ex amortization$4.20
Cash flow from operations$850M
Free cash flow$256M
Source: IFF FY2025 Form 10-K consolidated statements and company full-year summary. GAAP result: a reported loss including the $1,153M Food Ingredients goodwill impairment; the GAAP net-loss dollar figure and GAAP diluted EPS are not stated here because they were not verified from the 10-K text accessed — the adjusted figures above are the company’s non-GAAP measures and are labelled as such. No segment operating-profit split beyond adjusted operating EBITDA is stated.

KEY RISKS

  • Portfolio-shrink execution — the Food Ingredients sale (agreed May 2026 with CVC) and the Pharma exit change the perimeter; a delayed or repriced Food Ingredients deal would leave the largest segment (30.1% of sales) in limbo.
  • Impairment overhang — the $1,153M Food Ingredients goodwill impairment shows what happens when an acquired portfolio’s growth disappoints; further portfolio reviews could repeat it.
  • Customer concentration in formulations — losing a major food, beverage or personal-care customer’s formulation, or a shift to low-cost scent competition, hits volumes without a price offset.
  • Input and currency — natural-ingredient sourcing, energy and freight costs, plus a global manufacturing footprint in 44 countries, expose margins to commodity and foreign-exchange moves.
  • Regulatory and safety — flavour, fragrance and probiotic ingredients face evolving food-safety, labelling and chemical regulation in the EU, US and Asia.

WHY IT MATTERS FOR THE S&P 500

IFF is the S&P 500’s flavour-and-fragrance bellwether at a 0.03% weight and Materials rank #14: it maps consumer-staples innovation — what food, beverage and personal-care brands are putting into new products — better than any single brand owner can.

Its Taste and Scent win rates and the Food Ingredients disposal outcome are a read on packaged-goods R&D spending and on whether specialty-ingredients value sits with formulators or with commodity suppliers.

SOURCES & METHODOLOGY

Market dataSlickcharts S&P 500 by weight (rank, weight, price — Nov 3, 2026 crawl) · StockAnalysis (market cap — Nov 3, 2026 crawl, single source)
FinancialsIFF FY2025 Form 10-K (fiscal year ended Dec 31, 2025; filed Feb 2026, SEC EDGAR)
Sector classificationGICS via the List of S&P 500 companies (Wikipedia)
Library dataSPXSet logo library, compiled from company official websites, filings, or Wikipedia; as company logos are dynamic corporate information, no 100% guarantee is made for the graphics. SPXSet chart library, monthly bars, compiled from Yahoo public information.

Price Chart — 10-Year Monthly Candles

IFF

Source: Yahoo Finance monthly bars, split-adjusted · Data as of Sep 30, 2026 (last closed month) · SPXSet.com

FINANCIALS

繁體中文版

公司快照

股票代號IFF(NYSE)
公司International Flavors & Fragrances Inc.
GICS 板塊/行業原材料/Specialty Chemicals
標普500排名(按權重)第376名 · 0.03%(2026 年 11 月 3 日)
板塊內排名(按標普500權重)原材料第14名(2026 年 11 月 3 日)
總部美國紐約市
成立1889年(Polak & Schwarz;IFF於1958年成立)
行政總裁Erik Fyrwald(自2024年2月)
市值$23.52B(2026 年 11 月 3 日)
SEC 文件EDGAR — CIK 0000051253

業務概覽

國際香精香料創造其他公司產品中的味道、香氣及功能成分:香料及鹹味方案、食品成分及保護系統、酶、菌種及益生菌、香精化合物及化妝品活性成分。客戶為食品、飲料、家居、個人護理及製藥製造商;國際香精香料很少以自有品牌接觸消費者,因此其增長來自客戶配方及新產品訂單。

FY2025淨銷售額為108.90億美元,較FY2024的114.84億美元按申報基準下跌5%,但按可比匯率中性基準增長2%。毛利為39.38億美元(毛利率36.2%,計算值),經調整營業EBITDA為20.90億美元,利潤率19.2%。申報的GAAP業績為虧損,原因包括11.53億美元食品成分商譽減值及出售相關費用;GAAP淨虧損金額此處不列示,因未從所查閱的10-K文本中核實(見財務附註)。

投資組合正被刻意收縮至最強業務:2025年,國際香精香料把原Nourish分部拆分為Taste及食品成分,出售製藥方案及硝化纖維業務,啟動出售食品成分的程序,並於2026年5月同意把食品成分出售予CVC Capital Partners。自2026年第二季起,食品成分列為已終止經營業務。

分部淨銷售額 — FY2025

板塊淨銷售額佔比同比
食品成分$3,278M30.1%−3%*
Taste$2,481M22.8%+4%*
Scent$2,479M22.8%+3%*
健康與生物科學$2,283M21.0%+3%*
製藥方案$369M3.4%—
淨銷售額總計$10,890M100%−5%
來源:IFF FY2025 10-K分部披露。佔比按分部淨銷售額計算,四捨五入後合計100%。*分部同比數字為公司報告的可比匯率中性增長率,而非申報美元同比:2025年Taste/食品成分拆分下的上年分部銷售額未從所查閱的10-K文本中核實,故不列申報美元分部同比。製藥方案同比列為—,因該業務於2025年內出售,僅計入部分年度銷售額。FY2025分部經調整營業EBITDA:Taste 4.78億美元,健康與生物科學5.94億美元,Scent 5.15億美元;食品成分及製藥方案的經調整營業EBITDA此處不列示,因未從所查閱的10-K文本中核實。

歷史沿革

年份里程碑
1889年Polak & Schwarz由Leopold Schwarz及Joseph Polak於荷蘭聚特芬創立,從事香料、香精及香料貿易
1958年Polak & Schwarz與van Ameringen-Haebler合併,組成國際香精香料
2018年收購Frutarom,擴展天然香料、鹹味及天然成分業務
2021年與杜邦營養與生物科學合併,組成擴大後的國際香精香料成分及生物科學平台
2025年原Nourish分部拆分為Taste及食品成分;出售製藥方案及硝化纖維業務;確認11.53億美元食品成分商譽減值;啟動出售食品成分的正式程序

競爭地位

  • 配方鎖定 — 一旦國際香精香料的香料、酶或香精被指定用於客戶產品,重新配方既昂貴又耗時,帶來商品化學品供應商所沒有的多年收入可見度。
  • 香氣與味道規模 — Scent(24.79億美元)及Taste(24.81億美元)是食品成分以外兩個規模相近的第二引擎;健康與生物科學在三個已披露分部中經調整EBITDA利潤率最高(公司摘要稱26%)。
  • 生物科學深度 — 杜邦營養與生物科學合併帶來的酶、菌種及益生菌,為國際香精香料提供香料及香精以外的健康營養增長路徑。
  • 競爭 — 奇華頓、德之馨、帝斯曼-芬美意、Novonesis、嘉里及ADM在創新、天然成分採購及價格上爭奪香料、香精及生物科學成分市場。

財務快照 — FY2025

淨銷售額$10,890M(申報同比−5%;可比匯率中性+2%)
毛利$3,938M(毛利率36.2%,計算值)
經調整營業EBITDA$2,090M(利潤率19.2%)
經調整每股收益(不含攤銷)$4.20
經營現金流$850M
自由現金流$256M
來源:IFF FY2025 10-K合併報表及公司全年摘要。GAAP業績:計入11.53億美元食品成分商譽減值後的申報虧損;GAAP淨虧損金額及GAAP攤薄每股收益此處不列示,因未從所查閱的10-K文本中核實——上述經調整數字為公司非GAAP指標,已作標示。不列超出經調整營業EBITDA的分部營業利潤拆分。

主要風險

  • 收縮組合的執行 — 食品成分出售(2026年5月與CVC達成協議)及製藥業務退出改變了業務範圍;食品成分交易延遲或重新定價,會使最大分部(佔銷售30.1%)處於不確定狀態。
  • 減值風險 — 11.53億美元食品成分商譽減值顯示收購組合增長不如預期時的後果;進一步的組合審查可能重演。
  • 配方客戶集中 — 失去主要食品、飲料或個人護理客戶的配方,或低成本香精競爭加劇,會在沒有價格抵銷的情況下打擊銷量。
  • 投入及匯率 — 天然成分採購、能源及運費成本,加上遍佈44個國家的生產佈局,使利潤率面臨商品及外匯波動。
  • 監管及安全 — 香料、香精及益生菌成分在歐盟、美國及亞洲面臨不斷演變的食品安全、標籤及化學品監管。

對標普500的重要性

國際香精香料是標普500中香精香料的代表,權重0.03%,原材料板塊第14名:它比任何單一品牌擁有者更能反映消費必需品創新——食品、飲料及個人護理品牌在新產品中加入了什麼。

其Taste及Scent訂單勝率以及食品成分出售結果,是觀察包裝消費品研發支出,以及專業成分價值屬於配方商還是商品供應商的指標。

來源與方法

市場數據Slickcharts 標普500權重榜(排名、權重、價格——2026 年 11 月 3 日抓取)· StockAnalysis(市值——2026 年 11 月 3 日抓取,單一來源)
財務IFF FY2025 10-K(財政年度截至2025年12月31日;2026年2月提交,SEC EDGAR)
板塊分類GICS,據 S&P 500 公司清單(Wikipedia)
圖庫數據SPXSet logo 庫,整理自企業官方網站、文件或維基百科;由於是企業自身動態資訊,不對圖形做百分百保證。SPXSet 圖表庫月線,整理自 Yahoo 公開資訊。

10年股價K線圖(月K)

IFF

來源:Yahoo Finance 月 K(經拆股調整)· 數據截至 2026 年 9 月 30 日(最後已收月份)· SPXSet.com

財報

SPXSet Studio

SPXSet in-house research — market structure, options and volatility. Not investment advice.
SPXSet 站內獨立研究,聚焦 SPX 市場結構、期權與波動率;內容不構成投資建議。

SPXSet · Company Library · IFF
Data as of Nov 3, 2026 · Financials FY2025 (10-K) · Market data Nov 2026
Previous · Smurfit Westrock Plc (SW) — XLB Materials · S&P 500 Profile |史墨菲韋斯洛克公司介紹Next · Texas Pacific Land Corporation (TPL) — XLE Energy · S&P 500 Profile |德州太平洋土地公司介紹

Entered 2026-11-03 17:49 · updated 2026-11-14 05:09 · rev 5